| Symbol | AZTR |
|---|---|
| Name | AZITRA, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT 06405 |
| Telephone | (203) 489-0183 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001701478 |
| Description | None |
(10% Negative) AZITRA, INC. (AZTR) Announces Delay in Results Trials for ATR-COSF Program Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreNew Form SCHEDULE 13G - Azitra, Inc. <b>Filed:</b> 2026-06-25 <b>AccNo:</b> 0002044285-26-000008 <b>Size:</b> 6 KB
Read moreNew Form SCHEDULE 13D - Azitra, Inc. <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0001493152-26-029872 <b>Size:</b> 8 KB
Read moreNew Form SCHEDULE 13G - Azitra, Inc. <b>Filed:</b> 2026-06-22 <b>AccNo:</b> 0001440771-26-000008 <b>Size:</b> 20 KB
Read more(10% Negative) AZITRA, INC. (AZTR) Announces Delay in catalyst Trials for several Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreAzitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
Read more(99% Neutral) AZITRA, INC. (AZTR) Provides Update on scheduled for precision dermatology
Read moreAzitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
Read more